Affluent Medical SA (FR:AFME) has released an update.
Affluent Medical SA, a French medtech company, has announced the terms of participation for its upcoming Annual Ordinary and Extraordinary General Meeting scheduled for June 24, 2024. Shareholders are invited to attend the meeting at the company’s headquarters in Aix-en-Provence, with preparatory documents and participation details available on the company’s website. Affluent Medical specializes in innovative medical prostheses for urinary incontinence and cardiac mitral valve pathology, aiming to commercialize its products beginning early 2026.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.
